Matthew Biegler

Stock Analyst at Oppenheimer

(0)
# 4897
Out of 5,331 analysts
92
Total ratings
20.00%
Success rate
-27.43%
Average return
26 Stocks
Name Action PT Current % Upside Ratings Updated
VOR Vor Biopharma
Reiterates: Outperform
8 8
0.67 1094.03% 7 Mar 21, 2025
OLMA Olema Pharmaceutical...
Reiterates: Outperform
30 25
5.62 344.84% 5 Mar 19, 2025
ARVN Arvinas
Maintains: Outperform
40 45
7.69 485.18% 4 Feb 12, 2025
GILD Gilead Sciences
Reiterates: Outperform
105 115
103.64 10.96% 1 Dec 10, 2024
IDYA IDEAYA Biosciences
Reiterates: Outperform
53 53
21 152.38% 5 Oct 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
25 33
10.89 203.03% 6 Sep 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
20 20
1.45 1279.31% 7 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 6 Sep 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
17 15
5.67 164.55% 4 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
13 11
1.7 547.06% 1 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
114 125
104.69 19.4% 5 Jul 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Peer Perform
n/a
n/a n/a 4 Jul 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
16 14
5.62 149.11% 5 May 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Perform
n/a
n/a n/a 1 Apr 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
33 44
n/a n/a 1 Mar 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Perform
n/a
n/a n/a 5 Feb 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Perform
n/a
n/a n/a 2 Feb 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
8 3
n/a n/a 4 Aug 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
1500 450
n/a n/a 5 Aug 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
30
n/a n/a 1 Jun 2, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
25
1.42 1660.56% 1 Jun 2, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 3 Dec 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 Dec 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
520 360
10.15 3446.8% 1 Nov 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 3 Feb 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
115 105
n/a n/a 3 Jan 21, 2022